INTRODUCTION
Common dental procedures induce a transient bacteraemia. Decisions on whether to use antibiotic prophylaxis should weigh the risk of bacteraemia-inducing complications against the risk of adverse events from antibiotics, such as skin rashes, diarrhoea and anaphylaxis, and the risk of developing resistant bacterial strains. 1 In Sweden, most pharmaceutical committees in the counties devote resources to recommendations to support the optimal medication treatment for patients in healthcare. These recommendations include oral healthcare, with advice on when to administer antibiotic prophylaxis in connection Background Almost all (17/20) Swedish counties have pharmaceutical committees that establish recommendations for the use of antibiotic prophylaxis in oral healthcare. Objective To evaluate the evidence for the use of antibiotic prophylaxis in oral healthcare and the agreement between Swedish recommendations and evidence. Material and methods We conducted a systematic literature search in PubMed and the Cochrane Controlled Trials Register. The MeSH terms 'antibiotic prophylaxis' and 'dentistry' were used in the database search. Abstracts were reviewed according to specifi c inclusion and exclusion criteria. A total of 186 articles were read in full text by the four authors independently. Data extraction and interpretation of data was carried out using a pre-defi ned protocol. In the end, one case-control study was included for evaluation of evidence. Results The case-control study included patients with specifi c cardiac conditions. The study reported a 49% protective effi cacy (odds ratio: 0.51) of antibiotic prophylaxis for fi rst-time episodes of endocarditis within 30 days of procedure. This result was not statistically signifi cant. The quality of the evidence was low. No studies were evaluated on patients with other medical conditions. The recommendations included several cardiac and other medical conditions for which there is a lack of evidence or no evidence to support the use of antibiotic prophylaxis. Conclusions There is a lack of evidence to support the use of antibiotic prophylaxis. To avoid the risk of adverse events from antibiotics and the risk of developing resistant bacterial strains, the use of antibiotic prophylaxis should be minimised and recommendations in Sweden should be revised to be more evidence-based.
MATERIAL AND METHODS

Systematic review
In order to achieve a systematic approach, the literature review was adapted according to the method described by Goodman 10 and comprised the following steps: 1) problem specifi cation, 2) formulation of a plan for the literature search, 3) literature search and retrieval of publications, and 4) data extraction, interpretation of data, and evaluation of evidence from the literature retrieved.
Problem specifi cation
What is the evidence for the use of antibiotic prophylaxis in patients with specifi c medical conditions (cardiac condition, transplant, medical implant or compromised immune system due to disease or medication) to prevent infectious complications associated with dental procedures?
Defi nitions
'Antibiotic prophylaxis' is defi ned in the MeSH (Index Medicus: Medical Subject Headings) browser as 'use of antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure to prevent infectious complications' (http://www.ncbi. nlm.nih.gov).
'Dental procedure' is defi ned as a procedure performed by an oral health caregiver, for example dental assistant, dental hygienist or dentist. Tooth brushing was not included in this defi nition.
Formulation of a plan and search of the literature
In the fi rst step, publications were searched from PubMed and the Cochrane Controlled Trials Register by combining the MeSH terms 'antibiotic prophylaxis' and 'dentistry', which yielded 275 abstracts. The search was limited to studies in humans published in English, with an abstract and with an entry date in the period from 1 January 1996 to 9 February 2009. The year 1996 was chosen because the term 'antibiotic prophylaxis' was introduced as a MeSH term in that year.
We identifi ed relevant publications by examining all abstracts obtained from the PubMed search. The abstracts were examined independently by the four authors. The following medical conditions in the literature for antibiotic prophylaxis in dentistry were included:
Compromised immune system due to • disease or medication.
Studies on decision-making, theoretical analyses, cost-effectiveness analyses, patient compliance to instructions and the use of antibiotic prophylaxis in connection with primary healing after surgical procedures were excluded.
In the second step we searched the reference lists of all included publications from the fi rst step to identify additional publications. In this step, we only included primary studies. Thus systematic reviews, reviews, guidelines, and book chapters were excluded. There were no limits for publication date. References with a title containing the following key phrases were retrieved:
Antibiotic prophylaxis and a dental • procedure Antibiotic prophylaxis and a medical • condition (as specifi ed above)
A dental procedure and a medical • condition (as specifi ed above).
The abstracts of these references were retrieved and examined in the same manner as the abstracts yielded from the PubMed search. The literature search and retrieval of publications is presented in Figure 1 .
Data extraction and interpretation of data
Data extraction was performed according to a protocol. Each publication was read in full text individually by the four authors. When one of the authors considered a publication not relevant, it was discussed with the other authors to reach consensus of whether to exclude or not.
Remaining publications were then interpreted individually by the four authors according to a protocol. This protocol was developed according to Users' guides to the medical literature. II. How to use an article about therapy or prevention. 11, 12 Only studies with a matched control group were included.
Evaluation of evidence
Evaluation of evidence was based on study design, study quality, similarities between the patient populations, similarity of the comparison groups, size of confi dence intervals, and the direction and magnitude of results of individual studies, using a modifi ed version of the GRADE system. 13 The overall quality of the evidence was determined to be high, moderate, low or very low as described in the GRADE system.
RESULTS
Systematic literature search
As Figure 1 presents, the PubMed search resulted in 275 abstracts. After reading the abstracts and applying the inclusion and exclusion criteria, 154 remained. The second step of the search, the hand search of the reference lists of primary studies, reviews and guidelines, resulted in 32 additional publications. Thus, a total of 186 publications were retrieved and read in full text.
Data extraction and interpretation of data
Of the 186 publications which were read in full-text, 78 were primary studies, four were systematic reviews, 87 were reviews and 17 were guidelines. After data extraction and interpretation, only studies on Full-text publications included for data extraction (n = 186) Publications excluded (n = 166) (Systematic reviews, reviews, guidelines, and non-relevant publications)
Publications included for interpretation (n = 20)
Publications included for evaluation (n = 1 primary study)
Publications excluded (n = 19) 
Evaluation of evidence
There were no studies on medical conditions other than cardiac conditions. Only one study 15 provided evidence for the use of antibiotic prophylaxis in patients with cardiac conditions. The study by van der Meer et al. 15 included 248 patients, of which 34 received antibiotic prophylaxis. The results from this study presented a 49% nonsignifi cant protective effi cacy of antibiotic prophylaxis for fi rst-time episodes of endocarditis within 30 days of procedure. The confi dence interval was large and greater than 1 (90% CI: 0.11-2.29), which indicates equal risk in the groups, and thus no protective effi cacy. Based on this, the results are uncertain. The quality of the evidence was graded as low. 13 Thus, there is a lack of evidence to support the use of antibiotic prophylaxis in patients with cardiac conditions to prevent infectious complications associated with dental procedures.
Swedish recommendations and agreement with evidence
A total of 17/20 Swedish counties had recommendations developed by the pharmaceutical committees for the use of antibiotic prophylaxis. Three counties did not have recommendations concerning the use of antibiotic prophylaxis in oral healthcare. Thirteen counties used a joint recommendation and four counties had their own recommendation, which made a total of fi ve documents that were evaluated in this study. The recommendations were current during 2008. Of these, two were updated in 2008, one in 2007, one in 2005 and one in 1999. As presented in Table 2 , the recommendations included several medical conditions for consideration of antibiotic prophylaxis administration in connection with dental procedures. We have presented the medical conditions that were included in recommendations by using the exact terminologies that were used in the different documents. This means that some medical conditions are duplicated, for example 'not well controlled diabetes' is also included in 'diabetes' or 'compromised immune system' . The reason for this presentation was to illustrate the variety of terminologies that are used in recommendations.
All recommendations included cardiac conditions. There was consistency regarding the inclusion of patients with heart valve prosthesis, a previous episode of endocarditis and congenital heart disease. Some recommendations also included patients with heart valve surgery and acquired valvular disease. These are all medical conditions where there is a lack of evidence or no evidence for the effectiveness of antibiotic prophylaxis to prevent infectious complications.
DISCUSSION
Methodological considerations
The search limitations regarding language, only including publications with abstracts and not including unpublished data may have resulted in missing publications. We conducted a wide search, but it is always possible that there may be studies as of yet not identifi ed.
Randomised controlled trials offer the best protection against bias. However, nonrandomised studies may also add new insights. According to a study on 45 medical topics, there is a high correlation between randomised and nonrandomised trials in their estimates of effi cacy of intervention. 18 Therefore, we included nonrandomised studies.
cardiac conditions remained. The most common reason for exclusion was the lack of a control group of patients. Initially, three primary studies were included. [14] [15] [16] None of these were randomised controlled trials. However, after further interpretation of data, two of the primary studies were excluded. 14, 16 In these two studies, people with endocarditis that died (approximately 20% of potential cases in both studies) were excluded from the group of cases. The exclusion of these patients might have biased the results in these studies.
As presented in Table 1 , the only primary study that was fi nally included was a retrospective case-control study. 15 In this study by van der Meer et al., 15 the cases and controls were not compared in the usual way, where cases receive an intervention and controls do not. The difference between cases and controls was that cases comprised patients who had or were suspected of having bacterial endocarditis as defi ned by von Reyn's criteria. 17 Cases were included if they had congentital heart disease, coarctation of the aorta, rheumatic and other valvular dysfunction, or mitral valve prolapse with mitral regurgitation. Controls with a cardiac lesion and increased risk of endocarditis were included. In this study 15 the authors state that subjects with prosthetic heart valves were excluded because 1) they probably have a much higher risk of endocarditis and are a different risk group, and 2) there were too few patients with prosthetic valves for a case-control study. Antibiotic prophylaxis was given to some cases and some controls ( Table 1 ). The study 15 reported a 49% protective effi cacy (odds ratio: 0.51) of antibiotic prophylaxis for fi rst-time episodes of endocarditis within 30 days of procedure. This result was not statistically signifi cant, as reported in the study. 
Evidence
The quality of the evidence was low and we therefore conclude that there is a lack of evidence to support the use of antibiotic prophylaxis in patients with specifi c cardiac conditions to prevent infectious complications associated with dental procedures. This conclusion is in accordance with the results of the systematic reviews by Oliver et al., 6 Lockhart et al., 9 NICE 7 and Oliver et al. 8 However, in the study by van der Meer et al. 15 patients with prosthetic heart valves were not included. This means that we cannot dismiss the possibility that there could be a signifi cant protective effi cacy for this group of patients. Although there is a lack of evidence, the American Heart Association (AHA) argues that patients who would suffer the most severe consequences of an endocarditis episode should receive antibiotic prophylaxis. 2 The AHA includes the following cardiac conditions: prosthetic cardiac valve or prosthetic material used for cardiac valve repair, previous infective endocarditis, specifi ed types of congenital heart disease, and cardiac transplantation recipients who develop cardiac valvulopathy.
2 NICE has taken a more radical position and no longer recommends administration of antibiotic prophylaxis. 7 Regarding other medical conditions there was no evidence in the literature to support the use of antibiotic prophylaxis, a fact which is also reported by Lockhart et al. 9 It would be helpful to gain a higher level of evidence. The question is, would it be possible to perform studies that would increase the quality of evidence? The fact that the inclusion of all endocarditis cases in the Netherlands for two years produced only 44 appropriate cases 15 indicates the challenge. It would require large efforts to design and perform trials with adequate sample selection and size, appropriate controls and with clear outcomes. Such a study would probably need to involve several countries and centres. Reports of the number endocarditis cases that can be associated with dental procedures differ: some report 4% 19 and others as much as 14% of all cases. 20 Moreover, the fact that antibiotics may reduce but not completely eliminate bacteremia 21 and thus can result in patients having endocarditis despite antibiotics being administered appropriately, 22 adds to the complexity when designing future trials. Besides, when studying the risk of patients developing endocarditis, the patients' oral health status is another variable of interest. Patients' oral health status correlates with the occurrence of bacteremia 21 and could infl uence the risk of developing endocarditis. 23 Spontaneous bacteraemia from the oral cavity, which occurs during daily activities such as chewing or tooth brushing, is considered to cause a high percentage of endocarditis cases. 20 It is therefore reasonable to argue that the remaining 4-14% that are considered to be caused by dental procedures may also be caused by spontaneous bacteremias. 24 
Recommendations
Recommendations in Sweden included several cardiac conditions and other medical conditions for which there is lack of evidence or no evidence to support the use of antibiotic prophylaxis (Table 2) . However, based on consensus they included cardiac conditions that are also included in the AHA recommendations updated in 2007 2 or that were included in the AHA recommendations in 1997. 25 AHA is considered as a major authority and their recommendations are often the basis of other recommendations internationally. However, the recommendations also included several other medical conditions (Table 2) . patients because of over-use of an intervention, but rather concern shortcomings of interventions. Such an attitude would result in overutilisation. There is also the dilemma that a protective effi cacy that is very low on a population basis might be important to the individual patient. 15 More concern is also given to the growing phenomenon of bacterial resistance, which is caused by the use and abuse of antibiotics. Even though there is lack of data on the morbidity and mortality attributable to antibiotic resistance, we should not neglect this signifi cant threat to public health. 31 Arguments about the general risk of developing resistant bacterial strains might be considered too abstract and irrelevant to a clinician in the situation of a particular patient.
Pharmaceutical committees are the most common organisations issuing recommendations in Sweden. However, there are also other recommendations issued by, for example, infection clinics at hospitals, the public dental health service and the Swedish National Board of Health and Welfare. Recommendations differ as to which medical conditions are included and this might be confusing to GDPs. One way to decrease confusion might be to develop one document serving as a national recommendation. In previous studies we have shown that GDPs lack knowledge about which medical conditions and dental procedures should be considered for antibiotic prophylaxis administration according to recommendations. 26 There is a need for revisions of recommendations to be more evidence-based, but signifi cant efforts are also needed to implement recommendations in clinical practice. A successful implementation strategy must fi rst identify potential barriers. 32 However, even if consensus was achieved on a national level by developing a national recommendation document, other barriers might exist in the social context, for example reactions by colleagues. Furthermore, barriers such as knowledge, attitudes and habits might exist on the individual level. Previous studies reported that general dental practitioners (GDPs) in Sweden 26 and England 27 to a large extent administer antibiotic prophylaxis to patients with medical conditions such as renal transplants, diabetes and prosthetic joints. Even though there is no evidence for using antibiotic prophylaxis in patients with these medical conditions, GDPs were confi dent in their decisions on administration of antibiotic prophylaxis. 28 In Table 2 , we illustrate the variety of terminologies for medical conditions that are used in recommendations. Some of the terminology might be diffi cult to interpret by GDPs. For example it might be diffi cult to distinguish if a patient has a 'serious kidney disease', or which conditions could be included in 'inflammatory disease'. Furthermore, some recommendations specify types of 'congenital heart disease' for which antibiotic prophylaxis is warranted, for example 'unrepaired cyanotic congential heart disease' or 'repaired congenital heart disease with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device' (not presented in Table 2 ). This terminology is probably not understood by most GDPs in Sweden, since they are not educated in the defi nitions of different cardiac conditions and which cardiac conditions involve defi ciencies that warrant administration of antibiotic prophylaxis.
Several limitations in knowledge probably exist in GDPs' decisions on whether or not to administer antibiotic prophylaxis. When GDPs are in doubt about whether to administer antibiotic prophylaxis, and recommendations are unclear or ambiguous, they might decide to administer antibiotics 'just in case' . Since potential adverse events such as skin rashes and diarrhoea are not serious and anaphylaxis is a very rare consequence, GDPs might believe that they have more control over adverse events and would judge these risks as small. However, the most serious adverse reactions occur in patients with no history of allergy. 29 Antibiotic prophylaxis against endocarditis in connection with dental procedures may lead to a greater number of deaths through fatal anaphylaxis than a strategy of no prophylaxis. 30 Further, complaints of incorrect treatment to the Swedish National Board of Health and Welfare are seldom made by
